Main public logs

Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 03:34, 21 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1049.jpeg
• 16:05, 20 April 2024 Imam Ali Shah talk contribs created page Template:IAS (Created page with "Associate Editor-In-Chief: Imam Ali Shah, MBBS; Chandka Medical College, Larkana Pakistan")
• 16:30, 19 April 2024 Kosar Doraghi talk contribs created page Sparsentan (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox...")
• 16:24, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1046.jpeg
• 16:24, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1046.jpeg
• 16:14, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1045.jpeg
• 16:14, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1045.jpeg
• 16:11, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1047.jpeg
• 16:11, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1047.jpeg
• 16:05, 19 April 2024 Kosar Doraghi talk contribs created page File:IMG 1044.jpeg
• 16:05, 19 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1044.jpeg
• 19:33, 17 April 2024 Hafiza Amna Qadeer talk contribs created page SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY (Created blank page)
• 08:08, 17 April 2024 Edzelco talk contribs created page Elranatamab-bcmm (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:08, 17 April 2024 Edzelco talk contribs created page Palovarotene (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:08, 17 April 2024 Edzelco talk contribs created page Pozelimab-bbfg (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:07, 17 April 2024 Edzelco talk contribs created page Motixafortide (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:07, 17 April 2024 Edzelco talk contribs created page Momelotinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:06, 17 April 2024 Edzelco talk contribs created page Cipaglucosidase alfa-atga (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:05, 17 April 2024 Edzelco talk contribs created page Etrasimod (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:05, 17 April 2024 Edzelco talk contribs created page Zilucoplan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:04, 17 April 2024 Edzelco talk contribs created page Bimekizumab (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:04, 17 April 2024 Edzelco talk contribs created page Vamorolone (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:04, 17 April 2024 Edzelco talk contribs created page Mirikizumab-mrkz (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:03, 17 April 2024 Edzelco talk contribs created page Toripalimab-tpzi (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
• 08:02, 17 April 2024 Edzelco talk contribs created page Fruquintinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=fruquintinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy |fdaLIADAdult=Recommended Dosage The recommended dose of F...")
• 07:52, 17 April 2024 Edzelco talk contribs created page Taurolidine, heparin (Created page with "{{DrugProjectFormSinglePage |authorTag={{Edzelco}} |genericName=taurolidine, heparin |aOrAn=a |drugClass=combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant |indicationType=prevention |indication=atheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients...")
• 07:43, 17 April 2024 Edzelco talk contribs created page Repotrectinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=repotrectinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) |contraindications=None |warnings=5.1 Central Nervous System Adverse Reactions AUGTYRO can cause central nervous system adverse reactions. Among the 351 patients who received AUGTYRO in Study TRIDENT-1, a broad spectru...")
• 07:32, 17 April 2024 Edzelco talk contribs created page Efbemalenograstim alfa-vuxw (Created page with "{{DrugProjectFormSinglePage |genericName=efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=prevention |indication=incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |fdaLIADAdult=Recommended Dose: 20 mg administered subcutaneously once per chemotherapy cycle....")
• 05:50, 16 April 2024 Edzelco talk contribs created page Capivasertib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Capivasertib |aOrAn=a |drugClass=kinase inhibitor in combination with fulvestrant |indicationType=treatment |indication=adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least one endocrine-based...")
• 05:27, 16 April 2024 Edzelco talk contribs created page Iptacopan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=iptacopan |aOrAn=a |drugClass=complement factor B inhibitor |indicationType=treatment |indication=paroxysmal nocturnal hemoglobinuria |blackBoxWarningTitle=WARNING: SERIOUS INFECTIONS CAUSED BY ENCAPSULATED BACTERIA |blackBoxWarningBody=<span style="clear;"> FABHALTA increases the risk of serious and life-threatening infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria me...")
• 07:24, 15 April 2024 Edzelco talk contribs created page Vutrisiran (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=vutrisiran |aOrAn=a |drugClass=transthyretin-directed small interfering RNA |indicationType=treatment |indication=polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=pain in extremity, arthralgia, dyspnea, and decreased vitamin A levels. |fdaLIADAdult=Recommended Dosage The recommended dosage of AMVUTTRA is 25 mg administered by subcutaneous inj...")
• 20:06, 11 April 2024 User account Bilal Farhat Ali talk contribs was created by Alberto Castro Molina talk contribs
• 19:20, 10 April 2024 Kosar Doraghi talk contribs created page File:IMG 1037.jpeg
• 19:20, 10 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 1037.jpeg
• 23:28, 3 April 2024 Kosar Doraghi talk contribs created page File:IMG 0918.jpeg
• 23:28, 3 April 2024 Kosar Doraghi talk contribs uploaded File:IMG 0918.jpeg
• 20:13, 27 March 2024 M. Arsalan Bashir talk contribs created page User:M. Arsalan Bashir (Created page with "I’m an aspiring Neuroscientist and Neurology MD candidate, having earned my MBBS degree from Ziauddin University. My journey has led me to research, where I am wholeheartedly committed to enhancing treatment methods and increasing knowledge to challenge the stigma often linked with neurological conditions.") Tag: Visual edit
• 11:08, 27 March 2024 Imam Ali Shah talk contribs created page File:Bismuth Subnitrate Package and Label Display Panel.jpg
• 11:08, 27 March 2024 Imam Ali Shah talk contribs uploaded File:Bismuth Subnitrate Package and Label Display Panel.jpg
• 09:51, 27 March 2024 Imam Ali Shah talk contribs created page Bismuth subnitrate (Created page with "dasda") Tag: Visual edit
• 09:13, 26 March 2024 Imam Ali Shah talk contribs created page User:Imam Ali Shah (Created page with "=='''Imam Ali Shah, MBBS'''== Contact:Email: imamshah.med@gmail.com ==Medical Education== *'''2017-2022''' **MBBS Chandka Medical College, Pakistan ==Professional Affiliations== *Profesional Aff...")
• 08:33, 21 March 2024 Alara E. Dagsali talk contribs created page Norelgestromin (Created page with "{{DrugProjectFormSinglePage |authorTag=Alara E.Dagsali |OTC=Yes |genericName=NORELGESTROMIN AND ETHINLY ESTRADIOL patch |indicationType=prevention |indication=Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m for whom a combined hormonal contraceptive is appropriate. |hasBlackBoxWarning=Yes |adverseReactions=The following serious adverse reactions with the use of co...")
• 05:58, 21 March 2024 Kosar Doraghi talk contribs created page File:IMG 0885.jpeg
• 05:58, 21 March 2024 Kosar Doraghi talk contribs uploaded File:IMG 0885.jpeg
• 23:07, 19 March 2024 Kosar Doraghi talk contribs created page Ryzneuta (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]] |genericName=RYZNEUTA -Efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=treatment |indication=and decrease the incidence of infection, as manifested by [febrile neutropenia], in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |h...")
• 10:01, 12 March 2024 Hafiza Amna Qadeer talk contribs created page Rezafungin (Created page with "{{DrugProjectFormSinglePage |authorTag=HAFIZA AMNA QADEER |OTC=Yes |genericName=REZAFUNGIN |aOrAn=an |drugClass=echinocandin antifungal |indicationType=treatment }}")
• 17:24, 5 March 2024 User account Imam Ali Shah talk contribs was created by Alberto Castro Molina talk contribs
• 17:17, 5 March 2024 User account M. Arsalan Bashir talk contribs was created by Alberto Castro Molina talk contribs
• 18:02, 3 March 2024 Marshallsumter talk contribs created page Non-degenerate nucleotides per response element (Created page with " {| class="wikitable sortable" |+ Number of non-degenerate nucleotides versus number of response elements |- ! Number of nucleotides !! Letters of nucleotides !! Number of response elements !! Average ± deviation !! Order of list |- | 1 || A || 295 || 295.0 ± 0.0 || 1 |- | 1 || T || 285 || - || 1 |- | 1 || G || 286 || - || 3 |- | 1(4) || C || 300 || 291.5 ± 6 || 5 |- | 2 || AA || 105 || 105 ± 0.0 || 1 |- | 2 || AT || 105 || 105 ± 0.0 || 1 |- | 2 || TA || 74 |...")
• 02:16, 29 February 2024 Alen Antony talk contribs created page Lecanemab-irmb (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=lecanemab-irmb |aOrAn=a |drugClass=recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody |indicationType=treatment |indication=Alzheimer’s disease. This drug is ideally initiated during the early phase of dementia or mild cognitive impairment (which was the population tested in the clinical trials of this drug). |hasBlackBoxWarning=Yes |adverseReactions=Amyloid Related Imaging Abnorma...")